March 8th, 2025
This conference has already taken place.
Description
This program will provide an overview of management principles and best practices for complex patients with a range of
liver diseases, including hepatocellular carcinoma, viral hepatitis, fatty liver disease (MASLD), alcohol use disorder and
the spectrum of alcoholic liver disease, liver disease in pregnancy, and liver transplantation. Given the expected
increase in the burden of liver disease and liver cancer, it is essential to update practitioners on the latest clinical
guidelines and treatment strategies. This educational session aims to address existing gaps in knowledge and
management, providing healthcare professionals with the tools necessary to enhance their approach to liver disease
care. Topics to be covered include: management of Primary Biliary Cholangitis (PBC), liver disease during pregnancy, hepatic
manifestations of systemic immune disorders, updates in viral hepatitis and Hepatitis B (HBV), innovations in liver
transplantation, alcoholic liver disease, management of non-hepatic malignancies, advances in MASLD, the role of
artificial intelligence in hepatology, and co-management of cirrhosis with primary care providers.
For pricing information, see pricing tab below.
Dates and Times
Start: 3/8/2025 8:00 AM
End: 3/8/2025 2:00 PM
Agenda
7:30am – Registration and Breakfast
7:50 - Welcome/Opening Regards
8:00 – PBC Management
8:20 – Liver Disease and Pregnancy
8:40 – Hepatic Manifestations of Systemic Immune Disorders
9:00 – Viral Hepatitis Updates with HBV Focus
9:20 – Liver Transplant Innovation
10:00 – Q&A
10:30 – Break
11:00 – Alcoholic Liver Disease
11:20 – Management of Non-hepatic Malignancy
11:40 – Updates and Innovations in MASLD
12:00pm – AI in Hepatology
12:40 – Q & A
1:00 – Lunch & Learn: Co-management of Cirrhosis with PCP
2:00 – Conclusion
Pricing
| Tier | Price |
|---|---|
| Free | $0.00 |
Speakers
Location
Longaberger Alumni House
2200 Olentangy River Rd.
Columbus, OH 43202
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
Dr. Chathur Acharya, Dr. Kathleen Wyne, Dr. Khalid Mumtaz, Dr. Michael Wellner, Dr. Sylvester Black, Dr. Erin Bouquet, Dr. Vivek Mendiratta, Dr. Lindsay Sobotka, Dr. Sean Kelly, the faculty, the planners, the reviewers, and the CME provider have no relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in the educational activity.